Home/Filings/4/0001062993-24-005987
4//SEC Filing

Gilmour Duncan 4

Accession 0001062993-24-005987

CIK 0001036262other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:31 PM ET

Size

13.5 KB

Accession

0001062993-24-005987

Insider Transaction Report

Form 4
Period: 2024-03-06
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
  • Award

    Common Stock

    2024-03-06+7,35639,046 total
  • Award

    Common Stock

    2024-03-06+7,35546,401 total
  • Award

    Employee Stock Option (right to buy)

    2024-03-06+12,72412,724 total
    Exercise: $11.33Exp: 2034-03-05Common Stock (12,724 underlying)
Holdings
  • Employee Stock Option (right to buy)

    Exercise: $9.76Exp: 2032-03-08Common Stock (12,848 underlying)
    12,848
  • Employee Stock Option (right to buy)

    Exercise: $16.80Exp: 2031-06-13Common Stock (8,104 underlying)
    8,104
  • Common stock

    (indirect: By Spouse)
    200
  • Employee Stock Option (right to buy)

    Exercise: $16.06Exp: 2033-03-07Common Stock (8,044 underlying)
    8,044
Footnotes (6)
  • [F1]These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025.
  • [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 6, 2027 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 11,033.
  • [F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025.
  • [F4]This option vests in four equal annual installments commencing on March 8, 2024.
  • [F5]This option vests in four equal annual installments commencing on March 9, 2023.
  • [F6]This option vests in four equal annual installments commencing on June 14, 2022.

Issuer

INTEST CORP

CIK 0001036262

Entity typeother

Related Parties

1
  • filerCIK 0001866719

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:31 PM ET
Size
13.5 KB